Protein Sciences Corporation
Protein Sciences Corporation, a leading entity in the biotechnology industry, is headquartered in the United States. Founded in 1983, the company has made significant strides in the development of innovative protein-based solutions, particularly in the fields of vaccine production and biopharmaceuticals.
With a focus on advanced protein expression systems, Protein Sciences is renowned for its proprietary technologies, which enhance the efficiency and safety of vaccine manufacturing. Their flagship product, the Flublok® vaccine, stands out for its unique recombinant technology, offering a more effective alternative to traditional flu vaccines.
Recognised for its commitment to quality and innovation, Protein Sciences has established a strong market position, contributing to public health initiatives and advancing the biotechnology landscape. The company continues to play a pivotal role in addressing global health challenges through its cutting-edge research and development efforts.
+62 vs industry average
Protein Sciences Corporation’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Protein Sciences Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Protein Sciences Corporation yet.
Protein Sciences Corporation's reported carbon emissions
Protein Sciences Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sanofi, and as such, it inherits emissions data and climate commitments from its parent organisation.
While no absolute emissions figures are provided, Protein Sciences Corporation aligns its climate initiatives with those of Sanofi, which has established various reduction targets and commitments. These include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Sanofi at a corporate family level.
Despite the absence of specific emissions data, Protein Sciences Corporation is committed to sustainability and reducing its carbon footprint in line with industry standards. The company is expected to follow the climate strategies and reduction targets set by Sanofi, which are designed to mitigate climate impact and promote environmental responsibility.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Protein Sciences Corporation’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Protein Sciences Corporation yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from Sanofi
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Sanofi
RE 100
Inherited from Sanofi
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Protein Sciences Corporation
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project